Arrowstreet Capital, Limited Partnership Catalyst Biosciences, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$4.55 - $7.29 $373,127 - $597,823	-82,006 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$4.22 - $6.04 $22,391 - $32,048	5,306 Added 6.92%	82,006 $353,000
Q2 2020 Aug 12, 2020	BUY	$3.76 - $8.01 $288,392 - $614,367	76,700 New	76,700 $450,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.